| Intervention group (n = 24) | Control group (n = 22) | Total group (n = 46) | Chi-square (χ2) Anova (F) Fisher’s exact (Fe) |
---|---|---|---|---|
Age, yrs. | 42.2 (9.3) | 40.1 (9.0) | 41.2 (9.1) | F = .60 |
Sex, women % | 79.2 | 40.9 | 60.9 | χ2 = 7.05** |
Education2, n | 17 | 19 | 36 | Â |
 Low % | 18 | 26 | 22 | Fe = .75 |
 Middle % | 47 | 53 | 50 |  |
 High % | 35 | 21 | 28 |  |
 Hamilton-D173 | 20.1 (5.2) | 24.3 (5.4) | 22.1 (5.6) | F = 7.33* |
 Fitness parameters4, n | 24 | 20 | 44 |  |
 Wmax, Watt∙kg− 1 | 3.85 (.66) | 3.91 (.65) | 3.88 (.64) | F = 4.43* |
 VO2max, ml∙min−1∙kg− 1 | 29.1 (6.9) | 35.7 (6.0) | 31.6 (7.1) | F = 5.85* |
 Heartbeat at rest, b∙min−1 | 75.7 (12.3) | 80.0 (16.0) | 77.7 (12.2) | F = 1.10 |
 Grip strength5, kg, n | 18 | 16 | 34 |  |
 Left | 31.3 (13.2) | 33.6 (11.9) | 32.4 (12.5) | F = .29 |
 Right | 33.1 (16.6) | 38.6 (15.1) | 35.4 (15.8) | F = .84 |
Body composition, n | 24 | 22 | 46 | Â |
 BMI | 28.8 (5.9) | 27.3 (6.1) | 28.1 (6.0) | F = .70 |
 Fat Free Mass, kg | 51.2 (11.9) | 58.5 (13.1) | 54.7 (12.8) | F = 3.87 |
 Muscle Mass, kg | 27.0 (4.5) | 31.1 (4.8) | 29.0 (5.0) | F = 8.41* |
 Visceral Fat, kg | 8.3 (2.8) | 8.6 (4.5) | 8.4 (3.6) | F = .08 |
 Waist circumference, cm | 98.3 (13.5) | 97.4 (15.2) | 97.9 (14.2) | F = .05 |
 Blood pressure, n | 24 | 22 | 46 |  |
 Systolic, mmHg | 143.4 (24.2) | 143.0 (17.1) | 143.2 (20.9) | F = .00 |
 Diastolic, mmHg | 88.9 (12.5) | 88.0 (9.6) | 88.5 (11.1) | F = .07 |
Blood parameters6, n | 18 | 10 | 28 | Â |
 Fasting blood glucose, mmol∙l−1 | 4.9 (.44) | 5.1 (.56) | 5.0 (.48) | F = .598 |
 Cholesterol, mmol∙l−1 | 5.1 (.68) | 5.8 (1.33) | 5.3 (.99) | F = 2.99 |
 HDL Cholesterol, mmol∙l−1 | 1.33 (.36) | 1.55 (1.04) | 1.41 (.67) | F = .67 |
 Cholesterol/HDL Cholesterol, mmol∙l−1 | 4.0 (.98) | 4.7 (1.1) | 4.4 (1.8) | F = 2.43 |
 Triglycerides, mmol∙l−1 | 1.46 (.94) | 1.8 (1.17) | 1.5 (1.0) | F = .693 |
Anxiety: BAI7, n | 10 | 11 | 21 | Â |
18.5 (10.8) | 28.5 (13.1) | 23.7 (12.8) | F = 3.59 | |
Pain: GCPS8, n | 11 | 11 | 22 | Fe = .58 |
 A | 2 | 1 | 3 |  |
 B | 6 | 7 | 13 |  |
 C | 3 | 3 | 6 |  |
Pain medication % | 64 | 72 | 68 | F = .65 |
Quality of Life: EQ5-D9, n | 17 | 21 | 38 | Â |
37.5 (20.3) | 29.7 (16.3) | 33.2 (18.4) | F = 1.71 | |
Costs: TIC-P10, n | 19 | 21 | 40 | Â |
 Contact GP last 6 weeks % | 58 | 95 | 77 | Fe = .007** |
 Work Sickness leave < 1 month % | 85 | 85 | 85 | Fe = .70 |
 Work Sickness leave > 1 month % | 54 | 54 | 54 | Fe = .65 |
 Housework disability % | 71 | 77 | 74 | Fe = .66 |
 Housework help needed % | 47 | 61 | 54 | Fe = .52 |
Medication, n | 24 | 22 | 46 | Â |
 Antidepressant % | 74 | 86 | 72 | Fe = .44 |
 Benzodiazepines % | 42 | 68 | 50 | Fe = .12 |
 Mood stabilizer % | 16 | 4 | 10 | Fe = .32 |
 Antipsychotic % | 16 | 23 | 19 | Fe = .70 |
 Somatic medication % | 31 | 45 | 39 | Fe = .52 |
Duration antidepressant before inclusion |  |  |  | Fe = 1.0 |
 0–3 months % | 36 | 43 | 39 |  |
 3–6 months % | 50 | 47 | 48 |  |
  > 6 months % | 14 | 10 | 13 |  |